Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview

William "Bill" Ackman, founder and chief executive officer of Pershing Square Capital Management LP, pauses during a Bloomberg Television interview in New York, U.S., on Wednesday, April 23, 2014. Ackman already has a $1 billion paper gain on a newly disclosed 9.7 percent stake in Allergan Inc., helping to offset losses that his funds incurred through an earlier bet against Herbalife Ltd. Photographer: Scott Eells/Bloomberg via Getty Images
William "Bill" Ackman, founder and chief executive officer of Pershing Square Capital Management LP, pauses during a Bloomberg Television interview in New York, U.S., on Wednesday, April 23, 2014. Ackman already has a $1 billion paper gain on a newly disclosed 9.7 percent stake in Allergan Inc., helping to offset losses that his funds incurred through an earlier bet against Herbalife Ltd. Photographer: Scott Eells/Bloomberg via Getty Images
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
PURCHASE A LICENSE
How can I use this image?
$499.00
USD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
486251927
Collection:
Bloomberg
Date created:
April 23, 2014
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
VALEANT PERSHING